(Bloomberg) Neuralink Corp., Elon Musk’s brain-implant company, has raised $280 million in new funding from investors to develop its technology. Most Read from BloombergEveryone Wants to Work at UPS After Teamsters DealWeWork Tumbles After Raising ‘Substantial Doubt’ About FutureUS Bank Shares Drop as Moody’s Cuts Ratings, Warns on RisksWall Street WhatsApp, Texting Fines Exceed $2.5 BillionTesla CFO Kirkhorn Exits With $590 Million FortuneThe startup announced the funding round in a post on